Memorial Sisli Hospital
Memorial Sisli Hospital
Türkei, Istanbul
Betul Tavil
29 Jahre der Erfahrung
Akkredititationen :
Klinik ist zertifiziert :
Eine Stammzelltherapie bei Parkinson kostet in der Türkei für einen kompletten Behandlungszyklus üblicherweise zwischen $25,000 und $45,000. Die Kosten hängen von der Zellmenge, der Verabreichungsform wie der intrathekalen Injektion und dem Klinikstandort ab. Patienten sparen etwa 44% im Vergleich zu Deutschland, wo die Kosten durchschnittlich bei $45,000 liegen. Standardpakete enthalten meist den Eingriff, neurologische Diagnostik, Klinikaufenthalte und lokale Transfers.
Expertenmeinung von Bookimed: Eine Klinik mit integriertem Forschungszentrum bietet das beste Verhältnis von Sicherheit und Kosten. Professor Erdal Karaöz vom Liv Hospital Ulus gründete das erste staatlich anerkannte Stammzellzentrum der Türkei. Diese Erfahrung garantiert sterile Laborbedingungen und eine präzise Zelldifferenzierung. Während das Lokman Hekim University Ankara Hospital Einstiegspreise ab etwa 3.050 € anbietet, bieten erstklassige Istanbuler Kliniken JCI-akkreditierte Umgebungen für komplexe neurologische Fälle.
| Türkei | Österreich | Spanien | |
| Stammzelltherapie bei Parkinson | von $25,000 | von $35,000 | von $30,000 |
Tag 1
Tag 2
Tag 3-5
Tag 6
Tag 7-10
Woche 2-4
Woche 5
Woche 6
Bitte beachten Sie, dass der Fall jedes Patienten einzigartig ist und der Zeitrahmen je nach individuellem Zustand und Ansprechen auf die Behandlung variieren kann.
Prof. Baris Topcular, mit über 20 Jahren Erfahrung in der Neurologie, spezialisiert sich auf fortschrittliche Behandlungen wie die Stammzelltherapie bei Parkinson am Istanbul Florence Nightingale Hospital.
Dr. Asuman Mersin Kokrek verfügt über fundierte Kenntnisse in der Arbeitsmedizin und umfangreiche Erfahrung in Lehr- und Forschungskrankenhäusern.
Prof. Karaöz gründete das erste institutionelle Stammzellenforschungszentrum der Türkei – KÖGEM – und leistete Pionierarbeit bei der GMP-konformen Stammzellproduktion im Liv Hospital.
Dr. Anil Gurkan ist in der You Clinic auf die Stammzelltherapie bei Parkinson spezialisiert.
Geschrieben von Mariia Mytrofankina
Die Stammzellbehandlung zielt darauf ab, beschädigte Gehirnzellen zu regenerieren, um die Symptome der Parkinson-Krankheit zu lindern.
Stem cell therapy for Parkinson's in Turkey is an experimental procedure using mesenchymal stem cells to target neurological degeneration. While JCI-accredited clinics like Memorial Şişli Hospital maintain high clinical standards, the treatment remains in clinical trial phases rather than being a standardized, risk-free cure.
Bookimed Expert Insight: Advanced centers like Liv Hospital Ulus integrate GMP-certified laboratories led by specialists like Professor Erdal Karaöz. This infrastructure is critical because the safety of `off-label` stem cell use rests entirely on the clinic’s internal processing standards rather than international pharmacological regulations.
Patient Consensus: Many patients notice a brief `honeymoon` period of improved mobility for 1–3 months, but long-term symptom relief is rarely sustained. Typical feedback highlights that post-injection recovery involves several weeks of managing moderate fatigue and mild site soreness.
Success rates for Parkinson's stem cell therapy remain experimental, with clinical trials showing 86.5% to 100% of participants responding positively to motor symptom reduction. Recent phase 2 data indicates high-dose treatments can improve motor scores by 50% while increasing dopamine activity by 44.7% over 2 years.
Bookimed Expert Insight: Clinical data highlights a major experience gap in regenerative medicine. Professor Erdal Karaöz at Liv Hospital Ulus has published 190 articles and led 400+ stem cell treatments. Choosing a facility with a built-in GMP-certified laboratory, rather than an outpatient clinic, ensures higher cell viability and strictly controlled dosages for neurological protocols.
Patient Consensus: While clinical trials show high response rates, many patients report that initial improvements in tremors or rigidity may only last 2–3 months. It is vital to verify if a clinic uses PET scans to confirm actual dopamine increases rather than relying on subjective physical feelings.
Stem cell therapy cannot cure Parkinson disease as it remains an experimental treatment rather than a proven medical solution. While research into replacing dopamine-producing neurons is promising, current procedures focus on managing motor symptoms like tremors and rigidity rather than stopping the underlying neurodegeneration.
Bookimed Expert Insight: While many Turkish clinics like Liv Hospital Ulus maintain high-tier GMP-compliant laboratories, patients should distinguish between regenerative support and a cure. Leading specialists like Professor Erdal Karaöz emphasize that mesenchymal stem cells are currently used to manage progression, not provide a permanent recovery. Choosing a JCI-accredited facility in Istanbul ensures surgical safety even when the long-term neurological outcome remains clinically unproven.
Patient Consensus: Some travelers report temporary improvements in mood or sleep after treatment. Most find that baseline tremors and rigidity return after several weeks with no lasting changes in disease progression.
Ideal candidates for stem cell treatment include patients with chronic degenerative conditions like Parkinson's, osteoarthritis, or autoimmune diseases who have not responded to conventional therapies. Turkey provides advanced regenerative medicine in JCI-accredited facilities, where specialists use mesenchymal stem cells to reduce pain and improve neurological function.
Bookimed Expert Insight: Clinical data shows a high success rate at centers like Liv Hospital Ulus, which houses Turkey's first GMP-certified stem cell lab. While general stem cell therapy starts at $7,300, specialized Parkinson's protocols range from $25,000 to $45,000. Choosing a university-affiliated clinic like Lokman Hekim often ensures access to the latest allogeneic umbilical cord matrix-derived cell research.
Patient Consensus: Many patients emphasize that having realistic expectations is vital, focusing on gaining extra hours of functional on time daily. They often suggest traveling when symptoms are manageable, as heavy disability can lead to rejection during final clinical evaluations.
Select a Turkish clinic that provides mesenchymal stem cell therapy processed in Current Good Manufacturing Practice (cGMP) certified laboratories. Prioritize facilities with Joint Commission International (JCI) accreditation and neurological oversight by specialists like Professor Erdal Karaoz, who established Turkey's first private GMP stem cell lab.
Bookimed Expert Insight: While many clinics offer stem cell therapy, the infrastructure at Liv Hospital Ulus stands out. Their LivMedCell center was the first private Turkish facility to achieve GMP standards for stem cell production. This technical capacity often correlates with higher patient volumes, as they serve over 330,000 patients annually from 180 countries.
Patient Consensus: Patients emphasize the need for transparency regarding outcomes and warn against clinics making `guaranteed cure` claims. Peer-reviewed trial data and direct coordination with experienced neurologists are considered more reliable than promotional videos.